PurpleStride New Jersey Aims to Double Pancreatic Cancer Survival by 2020

Community Unites to Raise Awareness, Funds for Deadliest Major Cancer

PARSIPPANY, N.J.–(BUSINESS WIRE)–#PurpleStride–More patients die from pancreatic cancer than breast cancer, making
pancreatic cancer the third leading cause of cancer-related death in the
United States. Additionally, only
8 percent of patients live five years
. To change the course of this
disease, the Northern New Jersey Affiliate of the Pancreatic Cancer
Action Network is inviting the community to attend PurpleStride New

The event takes place during Pancreatic
Cancer Awareness Month
on Sunday, Nov. 13, at Mack Cali Business
Campus in Parsippany, days before World
Pancreatic Cancer Day
on Nov. 17. PurpleStride will raise much
needed awareness and funds to support the mission of the Pancreatic
Cancer Action Network to advance research, support patients and create

To register and to learn more visit www.purplestride.org/newjersey.

“After losing my dad to pancreatic cancer in 2011, I have been dedicated
to raising awareness and funds for this unrelenting disease,” stated
Dana Quinn, PurpleStride Chair of the Northern New Jersey Affiliate of
the Pancreatic Cancer Action Network and this year’s recipient of the
Randy Pausch Award. “Vice President Joe Biden put a stake in the ground
when he announced the Moonshot initiative which focuses on advancements
in cancer. New Jersey will come together to support this national
initiative in hopes of achieving our goal doubling pancreatic cancer
survival by 2020.”

The family-friendly 5K timed awareness walk/run will include:

  • Registration opens at 7:30 a.m.; event begins at 9 a.m.
  • Kid-friendly activities and “purple play zone”
  • Opening ceremony featuring live entertainment
  • Hosted by ABC 7’s Eyewitness News This Morning anchor Ken Rosato
  • National Presenting Sponsor: Celgene
  • Gold Media Sponsors: WABC-TV,
    NewsRadio 880
    , WFAN
    Sports Radio
  • National Silver Sponsor: AbbVie
  • Silver Sponsor: Rutgers
    Cancer Institute of New Jersey

The American Cancer Society reports an estimated 53,070
Americans will be diagnosed with pancreatic cancer and approximately
41,780 will die from the disease this year. The Pancreatic Cancer Action
Network is working to double survival by 2020 by continuing to directly
fund research, advocate for increased funding and resources from the
national government, raise awareness through community outreach, and
provide excellent patient services and support for novel initiatives
like Clinical
Trial Finder
, Know
Your TumorSM
personalized medicine service and
the Patient

Learn more about how you can support your local New Jersey Affiliate and
the Pancreatic Cancer Action Network by visiting www.pancan.org.
Click to view this year’s PurpleStride
and organizational

Follow the Pancreatic Cancer Action Network on TwitterInstagram or
on Facebook.

About the Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the national organization
creating hope in a comprehensive way through research, patient support,
community outreach and advocacy for a cure. The organization is leading
the way to increase survival for people diagnosed with this devastating
disease through a bold initiative — The Vision of Progress: Double
Pancreatic Cancer Survival by 2020. To continue to accelerate progress,
a goal to raise $200 million by 2020 is also in place. Together, we can
Wage Hope and rewrite the future of pancreatic cancer.


Members of the media are invited to attend the event, interview and
photograph participants, volunteers and special guests. Please contact
Lee at ldelosreyes@pancanvolunteer.org
to receive further press instructions.


Pancreatic Cancer Action Network – Northern New Jersey Affiliate
de los Reyes, Direct: (858) 248-1396
Media Relations Chair